ALUMIS INC. - Common Stock, $0.0001 par value per share (ALMS)
CUSIP: 022307102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 123,110,953
- Total 13F shares
- 78,328,492
- Share change
- +38,170,932
- Total reported value
- $234,986,451
- Put/Call ratio
- 216%
- Price per share
- $3.00
- Number of holders
- 112
- Value change
- +$114,158,793
- Number of buys
- 101
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 022307102?
CUSIP 022307102 identifies ALMS - ALUMIS INC. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 022307102:
Top shareholders of ALMS - ALUMIS INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AyurMaya Capital Management Company, LP |
13D/G
3/4/5
13F
|
Director, Other*, 10%+ Owner · Company |
16%
|
15,139,707
|
$65,554,931 | +$19,457,899 | 21 May 2025 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
4.7%
|
5,779,348
|
$35,485,197 | — | 31 Mar 2025 | |
| Foresite Capital Management VI LLC |
13F
|
Company |
3.4%
|
4,202,670
|
$25,804,394 | — | 31 Mar 2025 | |
| venBio Global Strategic Fund IV, L.P. |
13D/G
|
— |
4.8%
|
4,619,803
|
$21,297,292 | $0 | 30 Jun 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
2.7%
|
3,266,498
|
$20,056,298 | — | 31 Mar 2025 | |
| venBio Partners LLC |
13F
|
Company |
2.3%
|
2,787,398
|
$17,114,624 | — | 31 Mar 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.7%
|
2,147,396
|
$13,185,011 | — | 31 Mar 2025 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
1.6%
|
1,959,896
|
$12,033,761 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.3%
|
1,562,500
|
$9,593,750 | — | 31 Mar 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
1.2%
|
1,476,998
|
$9,068,768 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.2%
|
1,457,727
|
$8,950,444 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.76%
|
937,196
|
$5,754,384 | — | 31 Mar 2025 | |
| Fan Yu |
13F
|
Individual |
0.64%
|
789,618
|
$4,848,255 | — | 31 Mar 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
0.53%
|
653,223
|
$4,010,789 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.36%
|
443,699
|
$2,724,928 | — | 31 Mar 2025 | |
| TOWERVIEW LLC |
13F
|
Company |
0.35%
|
430,000
|
$2,640,200 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
228,998
|
$1,406,048 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
215,535
|
$1,323,385 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
155,073
|
$952,148 | — | 31 Mar 2025 | |
| CREDIT INDUSTRIEL ET COMMERCIAL |
13F
|
Individual |
0.11%
|
138,800
|
$852,232 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
127,854
|
$785,024 | — | 31 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.09%
|
109,669
|
$673,368 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
96,128
|
$590,226 | — | 31 Mar 2025 | |
| Sara Klein |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
213,796
mixed-class rows
|
$540,736 | — | 18 Feb 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
61,645
|
$378,500 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.04%
|
51,513
|
$316,290 | — | 31 Mar 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
0.04%
|
49,627
|
$304,710 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
42,403
|
$260,354 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
26,680
|
$163,815 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
26,444
|
$162,366 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
26,197
|
$160,850 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
24,150
|
$148,281 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
23,638
|
$145,137 | — | 31 Mar 2025 | |
| Alan Colowick |
3/4/5
|
Director |
—
class O/S missing
|
18,404
|
$137,910 | — | 01 Apr 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.02%
|
19,000
|
$116,660 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
18,374
|
$112,816 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
18,091
|
$111,078 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
18,055
|
$110,858 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.01%
|
17,097
|
$104,976 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
16,798
|
$103,140 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
16,543
|
$101,568 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
16,118
|
$98,964 | — | 31 Mar 2025 | |
| Scientech Research LLC |
13F
|
Company |
0.01%
|
13,566
|
$83,295 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
12,535
|
$76,965 | — | 31 Mar 2025 | |
| CAPSTONE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.01%
|
11,630
|
$71,408 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
10,700
|
$65,698 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
10,658
|
$65,440 | — | 31 Mar 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
10,420
|
$63,979 | — | 31 Mar 2025 | |
| Birchview Capital, LP |
13F
|
Company |
0.01%
|
10,000
|
$61,400 | — | 31 Mar 2025 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0.01%
|
9,472
|
$58,158 | — | 31 Mar 2025 |
Institutional Holders of ALUMIS INC. - Common Stock, $0.0001 par value per share (ALMS) as of Q2 2025
As of 30 Jun 2025,
ALUMIS INC. - Common Stock, $0.0001 par value per share (ALMS) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,328,492 shares.
The largest 10 holders included
AyurMaya Capital Management Company, LP, Foresite Capital Management V, LLC, SAMSARA BIOCAPITAL, LLC, venBio Partners LLC, Foresite Capital Management VI LLC, BlackRock, Inc., VANGUARD GROUP INC, Nextech Invest, Ltd., Trium Capital LLP, and Cormorant Asset Management, LP.
This page lists
112
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
72
Q2 2025 holders
112
Holder diff
40
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.